Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA
This article was originally published in The Tan Sheet
Executive Summary
FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s regulatory oversight of the products.
You may also be interested in...
OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.
OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.
Tracking Federal Agencies’ Enforcement In Supplement Space
““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.